HCW Biologics Inc (HCWB) — Long-term Investment Intensity
HCW Biologics Inc (HCWB) has a Long-term Investment Intensity of 18.1% as of June 2026. Long-term investments of $4.85 Million represent 18.1% of total assets of $26.77 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check HCWB financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
HCW Biologics Inc Long-term Investment Intensity (2020–2025)
This chart shows how HCW Biologics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the intensity stands at 18.1%, reflecting long-term investments of $4.85 Million against total assets of $26.77 Million USD. For the complete balance sheet picture, see HCW Biologics Inc (HCWB) total assets.
Annual Long-term Investment Intensity for HCW Biologics Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for HCW Biologics Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read HCWB current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 5.4% | $1.33 Million | $24.52 Million | ▲ +0.1 pp |
| 2024 | 5.3% | $1.60 Million | $30.24 Million | ▼ -0.3 pp |
| 2023 | 5.6% | $1.60 Million | $28.51 Million | ▲ +2.2 pp |
| 2022 | 3.4% | $1.60 Million | $46.81 Million | ▼ -18.1 pp |
| 2021 | 21.5% | $11.52 Million | $53.51 Million | ▲ +11.1 pp |
| 2020 | 10.4% | $1.60 Million | $15.40 Million | — |